CKD患者冠状动脉钙化进展与临床事件风险:CRIC研究
在1310例无心血管疾病史的CKD 2-4期患者中,平均3.3年内新发CAC与动脉粥样硬化性心血管病(HR 2.42)和全因死亡(HR 1.82)风险升高相关;CAC年增≥50 Agatston单位与全因死亡风险升高相关(HR 1.73),但与动脉粥样硬化性心血管病无关。
要点
- 基线无CAC的CKD患者新发CAC时动脉粥样硬化性心血管病和死亡风险显著升高。
- 基线已有CAC者年增≥50 Agatston单位与全因死亡风险升高相关。
- CAC进展与心力衰竭发生无关。
核心结论
- CKD 2-4期成人中,平均3.3年的CAC进展与新发动脉粥样硬化性心血管病和全因死亡风险升高相关,基线无CAC者关联最强。
研究设计与样本
- 前瞻性队列研究,纳入CRIC研究中1310例至少完成1次CAC扫描、无心血管疾病史且有CAC变化数据的参与者。
主要发现
- 基线无CAC者545例,平均3.3年内177例(32.5%)新发CAC;基线有CAC者765例,270例(35.3%)CAC年增≥50 Agatston单位。
- 多变量调整后,新发CAC与动脉粥样硬化性心血管病风险升高相关(HR 2.42,95% CI 1.23-4.79)。
- 新发CAC与全因死亡风险升高相关(HR 1.82,95% CI 1.03-3.22)。
- CAC年增≥50 Agatston单位与全因死亡风险升高相关(HR 1.73,95% CI 1.31-2.28),与动脉粥样硬化性心血管病无关(HR 1.42,95% CI 0.85-2.35)。
- CAC进展与心力衰竭发生无关。
临床怎么用
- 对CKD 2-4期患者,基线及随访CAC变化可能有助于识别动脉粥样硬化性心血管病和死亡高风险人群。
局限性
- 存在残余混杂,部分结局统计效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Coronary artery calcification (CAC) progresses rapidly in people with chronic kidney disease (CKD) compared with the general population. We studied the association between CAC progression and higher risks of atherosclerotic cardiovascular disease (CVD), congestive heart failure, and all-cause mortality among adults with CKD. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 1,310 participants in the Chronic Renal Insufficiency Cohort (CRIC) Study who had at least 1 CAC scan with no prior history of CVD and with observed or imputed data on changes in CAC over time. EXPOSURE: Observed or imputed CAC progression, categorized as incident CAC among participants with 0 CAC on the baseline scan or progressive CAC when the baseline scan demonstrated CAC and there was an increase in CAC≥50 Agatston units per year. OUTCOME: Atherosclerotic CVD (myocardial infarction or stroke), congestive heart failure, and all-cause mortality. ANALYTICAL APPROACH: Cause-specific Cox proportional hazards regression, stratified by presence of CAC at baseline. RESULTS: A total of 545 participants without and 765 with prevalent CAC at baseline were included. During a mean 3.3 years between CAC assessments, 177 participants (32.5%) without baseline CAC developed incident CAC while 270 participants (35.3%) with baseline CAC developed a≥50 Agatston units per year increase in CAC. After multivariable adjustment, incident CAC was associated with 2.42-fold higher rate of atherosclerotic CVD (95% CI, 1.23-4.79) and 1.82-fold higher rate of all-cause mortality (95% CI, 1.03-3.22). Progressive CAC (≥50 units per year) was not associated with atherosclerotic CVD (HR, 1.42 [95% CI, 0.85-2.35]) but was associated with a 1.73-fold higher rate of all-cause mortality (95% CI, 1.31-2.28). Progressive CAC was not associated with incident heart failure. LIMITATIONS: Residual confounding and limited statistical power for some outcomes. CONCLUSIONS: Among adults with CKD stages 2-4, CAC progression over a mean 3.3 years was associated with higher risk of atherosclerotic CVD and all-cause mortality. The associations were strongest among participants without CAC at baseline. PLAIN-LANGUAGE SUMMARY: Prior research has shown that coronary artery calcification (CAC) is a marker of higher risk of heart disease and death. Less is known about how changes in CAC over time might affect risk, particularly among patients with kidney disease. In this study, participants with chronic kidney disease who developed CAC or had worsening CAC over time showed higher rates of heart attack, stroke, and death than those who did not develop CAC. These findings support the need for further research on longitudinal changes in CAC as a possible aid to establishing prognosis among patients with kidney disease and to inform treatment.
引用
- Tian L, Jaeger BC, Scialla JJ, et al. Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study. Am J Kidney Dis. 2024. PMID: 39154888. doi:10.1053/j.ajkd.2024.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。